GlassScriptPhysician profile
Lynnette A Conrad
NPI 1881770931
$297.40
in general payments reported to CMS, 2019-2025
13 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.51 · 2022: $24.75 · 2023: $94.13 · 2024: $50.31 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $258.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $57.66 | 2025 | Veozah |
| Pfizer INC. | $53.44 | 2022-2024 | |
| Abbott Laboratories | $23.13 | 2025 | Freestyle Libre 3 |
| Amgen INC. | $22.76 | 2024 | Krystexxa |
| Bayer Healthcare Pharmaceuticals INC. | $19.46 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $18.37 | 2023 | Farxiga |
| Hologic Sales and Service, LLC | $18.31 | 2025 | Aptima |
| Lilly USA, LLC | $14.74 | 2023 | Jardiance |
| Abbvie INC. | $14.60 | 2025 | |
| Janssen Pharmaceuticals, INC | $14.51 | 2021 | |
| Merck Sharp & Dohme LLC | $14.42 | 2024 | Gardasil, Vaxelis, Capvaxive |
| Xeris Pharmaceuticals, INC. | $13.74 | 2023 | Gvoke Hypopen |
| Biohaven Pharmaceutical Holding Company LTD. | $12.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynnette Conrad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.